Two for the price of one: Antibody drugs work by binding to antigens such as extracellular proteins or receptors on a cell's surface, blocking their ability to function or targeting them for ...

Scientists have uncovered a powerful new antibody that disrupts a key protein helping triple-negative breast cancer survive and evade immunity. Triple-negative breast cancer (TNBC) is considered one ...

In its first bullet point in its release breaking down fourth quarter earnings, Regeneron said that sales of its coronavirus antibody treatment were $2.30 billion in the period, which represented a ...

The recent discovery of a novel antibody that works in an unusual way might inspire ideas for designing more effective vaccines. Among the common pathogens that could be targeted are urinary-tract ...

A first-in-human phase Ib study to evaluate the MEK inhibitor GDC-0973, combined with the pan-PI3K inhibitor GDC-0941, in patients with advanced solid tumors. This is an ASCO Meeting Abstract from the ...

From the 1980s, therapeutic protein drugs — monoclonal antibodies, proteins, antibody-drug conjugates, bispecific antibodies, etc. — have been widely employed in the treatment of HIV, tumors and other ...

GMT] In this webinar, presented in association with the journal mAbs, Drs. Crescioli and Reichert discuss recent trends in ...